Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Substrate Metabolism During Exercise Following Ingestion of Ethanol

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03404947
Recruitment Status : Completed
First Posted : January 19, 2018
Last Update Posted : March 6, 2019
Sponsor:
Information provided by (Responsible Party):
James Betts, University of Bath

Brief Summary:
This study will investigate how ethanol (pure alcohol) influences carbohydrate and fat metabolism during prolonged, moderate intensity exercise. Participants will perform two bouts of cycling exercise with or without prior ingestion of ethanol, in a randomised order, separated by one week.

Condition or disease Intervention/treatment Phase
Exercise Metabolism Following Ethanol Ingestion Dietary Supplement: Ethanol Not Applicable

Detailed Description:

Very little research has investigated the influence of ethanol on metabolism during prolonged exercise. Evidence suggests that delivery of fat to the working muscles during exercise may be limited with ethanol and therefore this may shift the relative proportions of energy derived from muscle stores of carbohydrate as a result (Jorfeldt & Juhlin-Dannfelt, 1976).

The current study aims to investigate how a small-moderate dose of ethanol influences where energy is derived from during a prolonged bout of moderate intensity cycling exercise.

Participants will visit the lab on three occasions, once for preliminary measurements of fitness and body composition, and twice for the experimental bouts of exercise. Body composition will be assessed using a dual-energy x-ray absorptiometry (DEXA) scan, which will measure lean mass, fat mass, and bone mineral density. Participants will then perform an incremental maximal oxygen uptake test to determine intensity for the experimental bouts of exercise.

The two experimental bouts of exercise include cycling on an exercise bike for 2 hours at 55% of their maximal oxygen uptake (i.e. fitness) following 1 hours rest. This will be performed under two conditions: with and without ethanol ingestion. Pre and post exercise muscle biopsies will be collected to assess muscle metabolism, with regular blood samples and expired breath samples being collected to further investigate fuel delivery and use by the working tissues. The experimental bouts of exercise will be performed 1 week apart in a randomised order.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Substrate Metabolism During 2 Hours of Moderate Intensity Exercise Following Ingestion of Ethanol in Man
Actual Study Start Date : November 13, 2017
Actual Primary Completion Date : June 29, 2018
Actual Study Completion Date : June 29, 2018

Resource links provided by the National Library of Medicine

Drug Information available for: Ethanol

Arm Intervention/treatment
Experimental: Ethanol
Participants will ingest ethanol (in the form of 40% ethanol) at an ingestion rate of 0.1 grams/kg lean body mass/hour in a solution with water.
Dietary Supplement: Ethanol
For one exercise session, participants will be asked to ingest a quantity of ethanol (in the form of vodka) sufficient to maximally stimulate liver alcohol metabolism.

No Intervention: No Ethanol
Participants will ingest a volume matched beverage of water only.



Primary Outcome Measures :
  1. Change in muscle glycogen content [ Time Frame: Change in muscle glycogen content over 2 hours of moderate intensity cycling exercise ]
    Muscle biopsy and subsequent biochemical analysis

  2. Blood glucose concentration [ Time Frame: Blood samples will be taken every 15 minutes during rest and the first hour of exercise, they will be taken every 30 minutes in the second hour of exercise. ]
    Venous blood samples will be taken and biochemically analysed for blood glucose concentration.

  3. Blood non-esterified fatty acid (NEFA) concentration [ Time Frame: Blood samples will be taken every 15 minutes during rest and the first hour of exercise, they will be taken every 30 minutes in the second hour of exercise. ]
    Venous blood samples will be taken and biochemically analysed for NEFA concentration.


Secondary Outcome Measures :
  1. Blood ethanol concentration [ Time Frame: Blood samples will be taken every 15 minutes during rest and the first hour of exercise, they will be taken every 30 minutes in the second hour of exercise. ]
    Venous blood samples will be taken and biochemically analysed for blood ethanol concentration.

  2. Blood lactate concentration [ Time Frame: Blood samples will be taken every 15 minutes during rest and the first hour of exercise, they will be taken every 30 minutes in the second hour of exercise. ]
    Venous blood samples will be taken and biochemically analysed for blood lactate concentration.

  3. Carbohydrate Oxidation [ Time Frame: Expired breath samples will be collected at baseline before beverage consumption and again after 1 hours rest. Samples will collected every 15 minutes during the first hour of exercise and every 30 minutes during the second hour ]
    Carbohydrate oxidation will be determined through indirect calorimetry via the douglas bag technique.

  4. Fat Oxidation [ Time Frame: Expired breath samples will be collected at baseline before beverage consumption and again after 1 hours rest. Samples will collected every 15 minutes during the first hour of exercise and every 30 minutes during the second hour ]
    Fat oxidation will be determined through indirect calorimetry via the douglas bag technique.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Habitual alcohol consumer (average 1-14 units per week)
  • BMI 18.5 - 29.9 kg/m2
  • Be able to attend the laboratory and willing to participate in necessary protocols
  • Be willing to undertake the durations of the exercise protocol (2 hours) ]
  • Have the capacity and willingness to provide informed consent (oral and written)

Exclusion Criteria:

  • Non-or excessive alcohol drinkers (0 or >14 units per week)
  • History of substance abuse
  • Habitual/previously habitual smokers
  • BMI >30.0 kg/m2
  • Experience contraindications to the administration of the proposed anaesthetic (Lidocaine Hydrochloride)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03404947


Locations
Layout table for location information
United Kingdom
University of Bath
Bath, Somerset, United Kingdom, BA2 7AY
Sponsors and Collaborators
University of Bath
Investigators
Layout table for investigator information
Principal Investigator: Harry Smith University of Bath
Principal Investigator: James Betts, PhD University of Bath
Publications:
Layout table for additonal information
Responsible Party: James Betts, Principal Investigator, University of Bath
ClinicalTrials.gov Identifier: NCT03404947    
Other Study ID Numbers: ETOH-hs565
First Posted: January 19, 2018    Key Record Dates
Last Update Posted: March 6, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by James Betts, University of Bath:
Exercise
Metabolism
Nutrition
Additional relevant MeSH terms:
Layout table for MeSH terms
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs